Oklo Inc. (NYSE:OKLO) Q4 2025 Earnings Call Transcript March 17, 2026 Oklo Inc. misses on earnings expectations. Reported EPS is $-0.28319 EPS, expectations were $-0.16971. Operator: Gentlemen, thank ...
Erez Raphael, Chief Executive Officer of DarioHealth Corp. He will be joined by our President and Chief Commercial Officer, ...
Joining me on today’s call are Sean Nolan, Taysha Gene Therapies, Inc.'s Chief Executive Officer; Sukumar Nagendran, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results